Sep 17, 2025 | H&P News, M&A
Basel / Berlin / Rostock, September 2025 – Hoffmann & Partner is pleased to announce that it has advised the shareholders of Nostos Genomics GmbH (“Nostos”) as M&A advisors in the successful acquisition by Limbus Medical Technologies GmbH (“Limbus”). Two...
Sep 3, 2025 | H&P News, M&A
For many entrepreneurs, selling their own company is the crowning glory of a lifetime of business – but also one of the biggest challenges.Successful business succession does not begin with the search for a successor or buyer, but with forward-looking preparation....
Aug 29, 2025 | Corporate Finance, H&P News, M&A
MaserGrup has made a strategic investment in Holle baby food, a Swiss pioneer in organic and biodynamic infant nutrition, as part of its international expansion into high-value, sustainable food categories. Holle baby food AG, founded in 1934 in Arlesheim...
Aug 12, 2025 | Corporate Finance, H&P News, M&A
Buy-side transactions are not a game of chance. They are based on analysis.In acquisition processes, investment decisions often have to be made under time pressure – with simultaneous information asymmetry between seller and buyer. Those who fail to ask the right...
Jul 24, 2025 | H&P News, M&A
This newsletter provides a comprehensive overview of M&A activity in the healthcare industry across the DACH region, with a particular focus on Switzerland. The analysis covers transactions from 2021 to 2024. At a glance: After a multi-year decline, healthcare...
Jul 3, 2025 | H&P News, M&A
The Basel-based energy service provider IWB is taking over the solar plant specialist Senero AG. In line with its strategy, IWB intends to further accelerate its growth with renewable energies in Switzerland. Senero is gaining support in the rapidly growing national...
